4//SEC Filing
Mulligan Seamus 4
Accession 0001765581-25-000042
CIK 0001232524other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 6:51 PM ET
Size
11.6 KB
Accession
0001765581-25-000042
Insider Transaction Report
Form 4
Mulligan Seamus
Director
Transactions
- Purchase
Ordinary Shares
2025-05-09$98.10/sh+80,684$7,915,472→ 80,684 total(indirect: By Nerano Pharma Lim) - Purchase
Ordinary Shares
2025-05-09$99.71/sh+100$9,971→ 100,000 total(indirect: By Nerano Pharma Lim) - Purchase
Ordinary Shares
2025-05-12$103.00/sh+1,621$166,962→ 101,621 total(indirect: By Nerano Pharma Lim) - Purchase
Ordinary Shares
2025-05-09$98.91/sh+19,216$1,900,678→ 99,900 total(indirect: By Nerano Pharma Lim)
Holdings
- 1,176,106
Ordinary Shares
Footnotes (4)
- [F1]Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $97.56 to $98.5542. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
- [F2]Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family.
- [F3]Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $98.56 to $99.47. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
- [F4]Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $102.97 to $103.00. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001536639
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 6:51 PM ET
- Size
- 11.6 KB